Exploring the therapeutic potential of tonic Chinese herbal medicine for gynecological disorders: An updated review
review
OA: closed
CC0
AI-generated summary
This review consolidates recent evidence on the therapeutic potential of tonic Chinese herbal medicine for various gynecological disorders.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Gynecological disorders have the characteristics of high incidence and recurrence rate, which sorely affects female's health. Since ancient times, traditional Chinese medicine (TCM), especially tonic medicine (TM), has been used to deal with gynecological disorders and has unique advantages in effectiveness and safety.
AIM OF THE REVIEW: In this article, we aim to summarize the research progress of TMs in-vivo and in-vitro, including their formulas, single herbs, and compounds, for gynecological disorders treatment in recent years, and to offer a reference for further research on the treatment of gynecological disorders and their clinical application in the treatment of TMs.
MATERIALS AND METHODS: Relevant information on the therapeutic potential of TMs against gynecological disorders was collected from several scientific databases including Web of Science, PubMed, CNKI, Google Scholar and other literature sources.
RESULTS: So far, there are 46 different formulas, 3 single herbs, and 24 compounds used in the treatment of various gynecological disorders such as premature ovarian failure, endometriosis breast cancer, and so on. Many experimental results have shown that TMs can regulate apoptosis, invasion, migration, oxidative stress, and the immune system. In addition, the effect of TMs in gynecological disorders treatment may be due to the regulation of VEGF, PI3K-AKT, MAPK, NF-κB, and other signaling pathways. Apparently, TMs play an active role in the treatment of gynecological disorders by regulating these signaling pathways.
CONCLUSION: TMs have a curative effect on the prevention and treatment of gynecological disorders. It could relieve and treat gynecological disorders through a variety of pathways. Therefore, the appropriate TM treatment program makes it more possible to treat gynecological disorders.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Anti‐Endometriotic Effects of Pueraria Flower Extract in Human Endometriotic Cells and Mice via openalex
- Bushen Wenyang Huayu Decoction inhibits autophagy by regulating the SIRT1-FoXO-1 pathway in endometriosis rats via openalex
- Endometriosis via openalex
- Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? via openalex
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology via openalex
- Fertility and infertility: Definition and epidemiology via openalex
- Impact of a Chinese Medicinal Formula, Xiao Liu Fang, on the “3A” Ability of Endometrial Stromal Cells in Patients with Endometriosis via openalex
- Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation via openalex
- Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals via openalex
- Kunling Wan improves oocyte quality by regulating the PKC/Keap1/Nrf2 pathway to inhibit oxidative damage caused by repeated controlled ovarian hyperstimulation via openalex
- Network Pharmacology Approach for Predicting Targets of Zishen Yutai Pills on Premature Ovarian Insufficiency via openalex
- Ningxin Tongyu Zishen Tang in Treatment of Premature Ovarian Insufficiency: A Retrospective Control Study via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Protopanaxadiol improves endometriosis associated infertility and miscarriage in sex hormones receptors-dependent and independent manners via openalex
- Si-Wu-Tang facilitates ovarian function through improving ovarian microenvironment and angiogenesis in a mouse model of premature ovarian failure via openalex
- Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis via openalex
- The effects of isoliquiritigenin on endometriosis in vivo and in vitro study via openalex
- Therapeutic Mechanism and Clinical Observation of Traditional Chinese Medicine Combined with Interventional Recanalization for Tubal Infertility via openalex
- Wenshen Xiaozheng Tang induces apoptosis and inhibits migration of ectopic endometriotic stromal cells via openalex
- Xiaoyao powder improves endometrial receptivity via VEGFR-2-mediated angiogenesis through the activation of the JNK and P38 signaling pathways via openalex
- W2976957583 via openalex
- W2984364835 via openalex
- W2994776681 via openalex
- W2995076033 via openalex
- W2995521689 via openalex
- W2995859967 via openalex
- W2999409656 via openalex
- W2999417355 via openalex
- W3002300448 via openalex
- W3002354512 via openalex
- W3002731584 via openalex
- W3005039094 via openalex
- W3009914522 via openalex
- W3012614716 via openalex
- W3027906585 via openalex
- W3034882778 via openalex
- W3035240843 via openalex
- W3042990016 via openalex
- W3046686624 via openalex
- W3049489219 via openalex
- W3082309540 via openalex
- W3083271936 via openalex
- W3085273061 via openalex
- W3086732443 via openalex
- W3099043519 via openalex
- W3104120128 via openalex
- W3111223737 via openalex
- W3117930094 via openalex
- W3118116773 via openalex
- W3121857123 via openalex
- W3122577587 via openalex
- W3128646645 via openalex
- W3133800313 via openalex
- W3135510251 via openalex
- W3137566303 via openalex
- W3155389257 via openalex
- W3163396248 via openalex
- W3171463007 via openalex
- W3177929771 via openalex
- W3184829665 via openalex
- W3188158128 via openalex
- W3188980615 via openalex
- W3195334570 via openalex
- W3197613404 via openalex
- W3202587434 via openalex
- W3205684877 via openalex
- W3207742119 via openalex
- W3216765159 via openalex
- W4200300980 via openalex
- W4205274147 via openalex
- W4205724345 via openalex
- W4205892660 via openalex
- W4207081653 via openalex
- W4210412081 via openalex
- W4210787542 via openalex
- W4211005384 via openalex
- W4213327350 via openalex
- W4213347502 via openalex
- W4221062233 via openalex
- W4221123479 via openalex
- W4224210016 via openalex
- W4225142378 via openalex
- W4226026570 via openalex
- W4234160457 via openalex
- W4281694941 via openalex
- W4282836266 via openalex
- W4283396255 via openalex
- W4283458456 via openalex
- W4283518639 via openalex
- W4284971201 via openalex
- W4285006236 via openalex
- W4285585588 via openalex
- W4286268170 via openalex
- W4287510184 via openalex
- W4289978408 via openalex
- W4290612173 via openalex
- W4295570935 via openalex
- W4295895755 via openalex
- W4296739206 via openalex
- W4297540329 via openalex
Source provenance
- europepmc
- last seen: 2026-06-22T06:15:23.361955+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-22T06:13:36.022245+00:00
License: CC0
· commercial use OK